S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

KNSA Kiniksa Pharmaceuticals International PLC

19.72

0.00 (0.00%)

Pre Market

Last Updated: 05:00:53

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Kiniksa Pharmaceuticals Charts.

Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Kiniksa Pharmaceuticals Charts.

Kiniksa Pharmaceuticals International PLC News

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 25 February 2025 (14 hours ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 25 February 2025 (14 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 25 February 2025 (23 hours ago) • Edgar (US Regulatory)

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution
Tuesday 25 February 2025 (23 hours ago) • GlobeNewswire Inc.

Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate Strategy
Tuesday 25 February 2025 (23 hours ago) • GlobeNewswire Inc.

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
Thursday 20 February 2025 (6 days ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 10 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 15 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance
Monday 13 January 2025 (1 month ago) • GlobeNewswire Inc.

More Kiniksa Pharmaceuticals International PLC News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions